Clinical TopicsWeb Exclusives

FDA approves Elelyso for Gaucher disease

On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.

Poll

Recent Posts